| 1. | gmucaria | |
| 2. | kotommi7947 | |
| 3. | tfeh1389 | |
| 4. | gary452849 | |
| 5. | lukeadlard |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | gmucaria 03/12/2018 Regeneron and Sanofi Announce Praluent Met Primary Endpoint of Reducing Cardiovascular Events |
| 2. | gary452849 01/23/2018 Cut to underweight, fun |
| 3. | tfeh1389 01/29/2018 Take it to the bank news :) - Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion). Company is payi… |
| 4. | kotommi7947 05/01/2018 Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients |
| 5. | lukeadlard 04/27/2018 Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER |
| 6. | gary452849 02/05/2018 Two emerging market drug companies |
| 7. | lukeadlard 04/25/2018 FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age |
| 8. | gary452849 04/03/2018 Regeneron Pharmaceuticals and Sanofi announced that the European Medicines Agency has accepted for review the… |
| 9. | kotommi7947 05/03/2018 Sanofi: Annual General Shareholders' Meeting of May 2, 2018 |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Sanofi
- SNY
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.